News
Fresh concerns have emerged about the platelet studies underpinning the FDA approval of ticagrelor, AstraZeneca's ...
4d
Zacks Investment Research on MSNWhy Astrazeneca (AZN) is a Top Momentum Stock for the Long-TermFor new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.Featuring daily updates of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results